In silico screening of bioactive compounds derived from Moringa oleifera Against SARS-CoV-2
International Journal of Drug Delivery Technology · 11.04.2026 · 16 (7s)
DOI: 10.25258/ijddt.16.7s.53 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 11.04.2026. Verfasst von Akshada A. Koparde und 4 weiteren Autor:innen.
Abstract (Originalsprache)
The World Health Organization recorded 323,610,370 COVID-19 cases, with 5,529,693 fatalities. SARS-CoV-2 is one of seven coronaviruses known to cause severe lower respiratory tract dysfunction. One of the most well-known and widely disseminated plant species is Moringa oleifera Lam. (Moringaceae family). The World Health Organization recorded 323,610,370 COVID-19 cases, with 5,529,693 fatalities. SARS-CoV-2 is one of seven coronaviruses known to cause severe lower respiratory tract dysfunction. One of the most well-known and widely disseminated plant species is Moringa oleifera Lam. (Moringaceae family). The 3D crystallographic structure of the COVID19 receptor (PDB ID-6M71, 6VYO, 6VYB, and 6Y2F) was obtained from the Protein Data Bank and utilized as a protein target for in-silico experiments. Molecular docking was performed using Auto Dock 4 and AutoDock Vina. A blind docking approach was employed to encompass all possible ligand binding sites. The binding free energy (kcal/mol) was utilized to calculate the binding affinity. This study reveals that M. oleifera, a polyphenolic compound, may possess antiviral activity against the COVID19 receptor responsible for SARS-CoV-2 disease, as predicted in silico. Molecular docking data suggests that Anthraquinone (-7.4, -7.8, -7.7,-8.3 Kcal/mol.) and Sitogluside(-7.4, -7.1, -8.4,-7.3 Kcal/mol) have greater activity than Serpentine (-7.2, -7.6, -6.8,-7.5 Kcal/mol). They have good binding energy. & they are good energy booster in covid 19 disease.
Zitieren
APA
Koparde, A. A., Mali, R. A., Jagdale, V. R., Shinde, N. A., & Ghate, S. V. (2026). In silico screening of bioactive compounds derived from Moringa oleifera Against SARS-CoV-2. International Journal of Drug Delivery Technology, 16(7s). https://doi.org/10.25258/ijddt.16.7s.53
Vancouver
Koparde AA, Mali RA, Jagdale VR, Shinde NA, Ghate SV. In silico screening of bioactive compounds derived from Moringa oleifera Against SARS-CoV-2. International Journal of Drug Delivery Technology. 2026;16(7s). doi:10.25258/ijddt.16.7s.53
BibTeX
@article{Koparde2026,
author = {Koparde, Akshada A. and Mali, Rohan A. and Jagdale, Vipul R. and Shinde, Nihal A. and Ghate, Shreyash V.},
title = {In silico screening of bioactive compounds derived from Moringa oleifera Against SARS-CoV-2},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {7s},
doi = {10.25258/ijddt.16.7s.53}
}
EUVIMED